Silexion Therapeutics Corp.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on SLXN yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Silexion Therapeutics filed an 8-K under Item 8.01 (Other Events) with the SEC. The filing's details are not included in the feed, so the nature of the event is unknown.
No SEC financials for SLXN yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.